191 related articles for article (PubMed ID: 8691261)
1. Brain acetylcholinesterase activity: validation of a PET tracer in a rat model of Alzheimer's disease.
Irie T; Fukushi K; Namba H; Iyo M; Tamagami H; Nagatsuka S; Ikota N
J Nucl Med; 1996 Apr; 37(4):649-55. PubMed ID: 8691261
[TBL] [Abstract][Full Text] [Related]
2. A simple method for the detection of abnormal brain regions in Alzheimer's disease patients using [11C]MP4A: comparison with [123I]IMP SPECT.
Ota T; Shinotoh H; Fukushi K; Nagatsuka S; Namba H; Iyo M; Aotsuka A; Tanaka N; Sato K; Shiraishi T; Tanada S; Arai H; Irie T
Ann Nucl Med; 2004 May; 18(3):187-93. PubMed ID: 15233279
[TBL] [Abstract][Full Text] [Related]
3. Kinetic analysis of [(11)C]MP4A using a high-radioactivity brain region that represents an integrated input function for measurement of cerebral acetylcholinesterase activity without arterial blood sampling.
Nagatsuka Si S; Fukushi K; Shinotoh H; Namba H; Iyo M; Tanaka N; Aotsuka A; Ota T; Tanada S; Irie T
J Cereb Blood Flow Metab; 2001 Nov; 21(11):1354-66. PubMed ID: 11702050
[TBL] [Abstract][Full Text] [Related]
4. In vivo evaluation of N-[18F]fluoroethylpiperidin-4ylmethyl acetate in rats compared with MP4A as a probe for measuring cerebral acetylcholinesterase activity.
Kikuchi T; Okamura T; Zhang MR; Fukushi K; Irie T
Synapse; 2010 Mar; 64(3):209-15. PubMed ID: 19862687
[TBL] [Abstract][Full Text] [Related]
5. N-[18F]fluoroethyl-4-piperidyl acetate ([18F]FEtP4A): A PET tracer for imaging brain acetylcholinesterase in vivo.
Zhang MR; Furutsuka K; Maeda J; Kikuchi T; Kida T; Okauchi T; Irie T; Suzuki K
Bioorg Med Chem; 2003 Jun; 11(12):2519-27. PubMed ID: 12757720
[TBL] [Abstract][Full Text] [Related]
6. Positron emission tomographic measurement of brain acetylcholinesterase activity using N-[(11)C]methylpiperidin-4-yl acetate without arterial blood sampling: methodology of shape analysis and its diagnostic power for Alzheimer's disease.
Tanaka N; Fukushi K; Shinotoh H; Nagatsuka S; Namba H; Iyo M; Aotsuka A; Ota T; Tanada S; Irie T
J Cereb Blood Flow Metab; 2001 Mar; 21(3):295-306. PubMed ID: 11295884
[TBL] [Abstract][Full Text] [Related]
7. Dementia with Lewy bodies can be well-differentiated from Alzheimer's disease by measurement of brain acetylcholinesterase activity-a [11C]MP4A PET study.
Shimada H; Hirano S; Sinotoh H; Ota T; Tanaka N; Sato K; Yamada M; Fukushi K; Irie T; Zhang MR; Higuchi M; Kuwabara S; Suhara T
Int J Geriatr Psychiatry; 2015 Nov; 30(11):1105-13. PubMed ID: 26280153
[TBL] [Abstract][Full Text] [Related]
8. N-[18F] fluoroethylpiperidin-4ylmethyl acetate, a novel lipophilic acetylcholine analogue for PET measurement of brain acetylcholinesterase activity.
Kikuchi T; Zhang MR; Ikota N; Fukushi K; Okamura T; Suzuki K; Arano Y; Irie T
J Med Chem; 2005 Apr; 48(7):2577-83. PubMed ID: 15801847
[TBL] [Abstract][Full Text] [Related]
9. A method to predict the ratio of the tracer conversion rate to the tracer back-diffusion rate of an irreversible-type radiotracer in humans by preclinical evaluations.
Ohya T; Zhang MR; Fukumura T; Fukushi K; Kikuchi T; Irie T
Nucl Med Commun; 2012 Oct; 33(10):1019-23. PubMed ID: 22850605
[TBL] [Abstract][Full Text] [Related]
10. Positron emission tomography: quantitative measurement of brain acetylcholinesterase activity using radiolabeled substrates.
Namba H; Fukushi K; Nagatsuka S; Iyo M; Shinotoh H; Tanada S; Irie T
Methods; 2002 Jul; 27(3):242-50. PubMed ID: 12183113
[TBL] [Abstract][Full Text] [Related]
11. In-vivo measurements of regional acetylcholine esterase activity in degenerative dementia: comparison with blood flow and glucose metabolism.
Herholz K; Bauer B; Wienhard K; Kracht L; Mielke R; Lenz MO; Strotmann T; Heiss WD
J Neural Transm (Vienna); 2000; 107(12):1457-68. PubMed ID: 11458998
[TBL] [Abstract][Full Text] [Related]
12. Voxel-Based Acetylcholinesterase PET Study in Early and Late Onset Alzheimer's Disease.
Hirano S; Shinotoh H; Shimada H; Ota T; Sato K; Tanaka N; Zhang MR; Higuchi M; Fukushi K; Irie T; Kuwabara S; Suhara T
J Alzheimers Dis; 2018; 62(4):1539-1548. PubMed ID: 29562505
[TBL] [Abstract][Full Text] [Related]
13. Brain acetylcholinesterase activity in mild cognitive impairment and early Alzheimer's disease.
Rinne JO; Kaasinen V; Järvenpää T; Någren K; Roivainen A; Yu M; Oikonen V; Kurki T
J Neurol Neurosurg Psychiatry; 2003 Jan; 74(1):113-5. PubMed ID: 12486280
[TBL] [Abstract][Full Text] [Related]
14. In vivo study of acetylcholine esterase in basal forebrain, amygdala, and cortex in mild to moderate Alzheimer disease.
Herholz K; Weisenbach S; Zündorf G; Lenz O; Schröder H; Bauer B; Kalbe E; Heiss WD
Neuroimage; 2004 Jan; 21(1):136-43. PubMed ID: 14741650
[TBL] [Abstract][Full Text] [Related]
15. Human cerebral acetylcholinesterase activity measured with positron emission tomography: procedure, normal values and effect of age.
Namba H; Iyo M; Fukushi K; Shinotoh H; Nagatsuka S; Suhara T; Sudo Y; Suzuki K; Irie T
Eur J Nucl Med; 1999 Feb; 26(2):135-43. PubMed ID: 9933347
[TBL] [Abstract][Full Text] [Related]
16. Measurement of acetylcholinesterase by positron emission tomography in the brains of healthy controls and patients with Alzheimer's disease.
Iyo M; Namba H; Fukushi K; Shinotoh H; Nagatsuka S; Suhara T; Sudo Y; Suzuki K; Irie T
Lancet; 1997 Jun; 349(9068):1805-9. PubMed ID: 9269216
[TBL] [Abstract][Full Text] [Related]
17. In vivo brain incorporation of [1-14C]arachidonate in awake rats, with or without cholinergic stimulation, following unilateral lesioning of nucleus basalis magnocellularis.
Nariai T; DeGeorge JJ; Lamour Y; Rapoport SI
Brain Res; 1991 Sep; 559(1):1-9. PubMed ID: 1723641
[TBL] [Abstract][Full Text] [Related]
18. PET probes for imaging brain acetylcholinesterase.
Kikuchi T; Okamura T; Zhang MR; Irie T
J Labelled Comp Radiopharm; 2013; 56(3-4):172-9. PubMed ID: 24285323
[TBL] [Abstract][Full Text] [Related]
19. Acetylcholinesterase imaging: its use in therapy evaluation and drug design.
Shinotoh H; Fukushi K; Nagatsuka S; Irie T
Curr Pharm Des; 2004; 10(13):1505-17. PubMed ID: 15134572
[TBL] [Abstract][Full Text] [Related]
20. Long-term effects of selective immunolesions of cholinergic neurons of the nucleus basalis magnocellularis on the ascending cholinergic pathways in the rat: a model for Alzheimer's disease.
Szigeti C; Bencsik N; Simonka AJ; Legradi A; Kasa P; Gulya K
Brain Res Bull; 2013 May; 94():9-16. PubMed ID: 23357177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]